Taubert Jennifer L
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Taubert Jennifer L. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| JNJ | EVP, WWC. Innovative Medicine | Sale | 56,471 | $177.81 | $10,041,109 | Sep 4, 2025 |
| JNJ | EVP, WWC. Innovative Medicine | Option Exercise | 1,302 | — | — | Feb 18, 2025 |
| JNJ | EVP, WWC. Innovative Medicine | Option Exercise | 58,504 | $100.06 | $5,853,910 | Feb 7, 2025 |
| JNJ | EVP, WWC. Innovative Medicine | Option Exercise | 1,302 | — | — | Feb 13, 2024 |
| JNJ | EVP, WWC. Innovative Medicine | Tax Withholding | 13,403 | $157.40 | $2,109,632 | Feb 12, 2024 |
| JNJ | EVP, WW Chair, Pharmaceuticals | Sale | 59,397 | $156.27 | $9,281,969 | Feb 8, 2024 |
| JNJ | EVP, WW Chair, Pharmaceuticals | Tax Withholding | 10,569 | $162.01 | $1,712,284 | Feb 13, 2023 |
| JNJ | EVP, WW Chair, Pharmaceuticals | Option Exercise | 3,570 | — | — | Feb 10, 2023 |
| JNJ | EVP, WW Chair, Pharmaceuticals | Sale | 76,923 | $176.78 | $13,598,448 | Nov 22, 2022 |
| JNJ | EVP, WW Chair, Pharmaceuticals | Option Exercise | 18,064 | — | — | Feb 15, 2022 |
| JNJ | EVP, WW Chair, Pharmaceuticals | Option Exercise | 3,297 | — | — | Feb 14, 2022 |
| JNJ | EVP, WW Chair, Pharmaceuticals | Tax Withholding | 5,268 | $165.55 | $872,117 | Feb 12, 2021 |
| JNJ | EVP, WW Chair, Pharmaceuticals | Tax Withholding | 4,277 | $150.46 | $643,517 | Feb 13, 2020 |
| JNJ | EVP, WW Chair, Pharmaceuticals | Tax Withholding | 23,721 | $149.32 | $3,542,020 | Feb 3, 2020 |
| JNJ | EVP, WW Chair, Pharmaceuticals | Tax Withholding | 6,236 | $131.94 | $822,778 | Feb 11, 2019 |